Catalyst Wire Dossier Catalyst Wire Dossier

Vespireit

· Valenta Pharm JSC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Vespireit, covering 2025-06-15 to 2025-06-15. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Vespireit, Prolonged-release Tablets, in Patients With Autonomic Dysfunction Syndrome Accompanied by Functional Vertigo [Phase 4]

See pricing